Geode Capital Management’s Lakewood-Amedex Biotherapeutics LABT Stock Holding History
Bought
Maintained
Sold
Other funds holding LABT
Geode Capital Management's LABT Position: Q3 2026 in Review
Geode Capital Management opened a new position in Lakewood-Amedex Biotherapeutics (LABT) in Q3 2026: 44,800 shares worth $42.8K. The stake represents ﹤0.01% of the portfolio and ranks #4232 among its holdings.
7 funds tracked by Wall St. Rank hold LABT as of Q3 2026.
- Geode Capital Management held 44,800 shares of Lakewood-Amedex Biotherapeutics worth $42.8K as of Q3 2026.
- Lakewood-Amedex Biotherapeutics was a new Geode Capital Management position in Q3 2026.
- Lakewood-Amedex Biotherapeutics made up ﹤0.01% of Geode Capital Management's portfolio in Q3 2026, its #4232 holding.
- 7 funds tracked by Wall St. Rank held Lakewood-Amedex Biotherapeutics as of Q3 2026.
Based on Geode Capital Management's 13F filing for Q3 2026, filed 6 Nov 2026.